Items where Author is "Ellis, IO"
 | Up a level |
Journal article
ABDEL-FATAH, T.M.A., THANGAVELU, P.U., REID, L.E., MCCART REED, A.E., SAUNUS, J.M., DUIJF, P.H.G., SIMPSON, P.T., LAKHANI, S.R., BALL, G.R., PONGOR, L., GYORFFY, B., MOSELEY, P.M., GREEN, A.R., POCKLEY, A.G., CALDAS, C., ELLIS, I.O. and CHAN, S.Y.T., 2020. Association of sperm-associated antigen 5 and treatment response in patients With estrogen receptor–positive breast cancer. JAMA Network Open, 3 (7): e209486. ISSN 2574-3805
ALSALEEM, M.A., BALL, G., TOSS, M.S., RAAFAT, S., ALESKANDARANY, M., JOSEPH, C., OGDEN, A., BHATTARAI, S., RIDA, P.C.G., KHANI, F., DAVIS, M., ELEMENTO, O., ANEJA, R., ELLIS, I.O., GREEN, A., MONGAN, N.P. and RAKHA, E., 2020. A novel prognostic two-gene signature for triple negative breast cancer. Modern Pathology. ISSN 0893-3952
KOTECHA, S., LEBOT, M.N., SUKKARN, B., BALL, G., MOSELEY, P.M., CHAN, S.Y., GREEN, A.R., RAKHA, E., ELLIS, I.O., MARTIN, S.G. and STORR, S.J., 2019. Dopamine and cAMP-regulated phosphoprotein 32 kDa (DARPP-32) and survival in breast cancer: a retrospective analysis of protein and mRNA expression. Scientific Reports, 9: 16987. ISSN 2045-2322
RAKHA, E.A., ALESKANDARANI, M., TOSS, M.S., GREEN, A.R., BALL, G., ELLIS, I.O. and DALTON, L.W., 2018. Breast cancer histologic grading using digital microscopy: concordance and outcome association. Journal of Clinical Pathology. ISSN 0021-9746
MARTIN, S.G., LEBOT, M.N., SUKKARN, B., BALL, G., GREEN, A.R., RAKHA, E.A., ELLIS, I.O. and STORR, S.J., 2018. Low expression of G protein-coupled oestrogen receptor 1 (GPER) is associated with adverse survival of breast cancer patients. Oncotarget, 9 (40), pp. 25946-25956. ISSN 1949-2553
RAKHA, E.A., AGARWAL, D., GREEN, A.R., ASHANKYTY, I., ELLIS, I.O., BALL, G. and ALASKANDARANY, M.A., 2017. Prognostic stratification of oestrogen receptor-positive HER2-negative lymph node-negative class of breast cancer. Histopathology, 70 (4), pp. 622-631. ISSN 0309-0167
ARORA, A., PARVATHANENI, S., ALESKANDARANY, M.A., AGARWAL, D., ALI, R., ABDEL-FATAH, T., GREEN, A.R., BALL, G.R., RAKHA, E.A., ELLIS, I.O., SHARMA, S. and MADHUSUDAN, S., 2017. Clinicopathological and functional significance of RECQL1 helicase in sporadic breast cancers. Molecular Cancer Therapeutics, 16 (1), pp. 239-250. ISSN 1535-7163
ABDEL-FATAH, T.M.A., REES, R.C., POCKLEY, A.G., MOSELEY, P., BALL, G.R., CHAN, S.Y.T., ELLIS, I.O. and MILES, A.K., 2017. The localisation of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2. Oncotarget, 8, pp. 112245-112257. ISSN 1949-2553
ABDEL-FATAH, T.M.A., AGARWAL, D., LIU, D.X., RUSSELL, R., RUEDA, O.M., LIU, K., XU, B., MOSELEY, P.M., GREEN, A.R., POCKLEY, A.G., REES, R.C., CALDAS, C., ELLIS, I.O., BALL, G.R. and CHAN, S.Y.T., 2016. SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis. The Lancet Oncology, 17 (7), pp. 1004-1018. ISSN 1470-2045
SHAMANNA, R.A., LU, H., CROTEAU, D.L., ARORA, A., AGARWAL, D., BALL, G., ALESKANDARANY, M.A., ELLIS, I.O., POMMIER, Y., MADHUSUDAN, S. and BOHR, V.A., 2016. Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer. Oncotarget, 7 (12). ISSN 1949-2553
ALESKANDARANY, M.A., AGARWAL, D., NEGM, O.H., BALL, G., ELMOUNA, A., ASHANKYTY, I., NUGLOZEH, E., FAZALUDEEN, M.F., DIEZ-RODRIGUEZ, M., NOLAN, C.C., TIGHE, P.J., GREEN, A.R., ELLIS, I.O. and RAKHA, E.A., 2016. The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts. Breast Cancer Research and Treatment, 156 (1), pp. 9-20. ISSN 0167-6806
ABDEL-FATAH, T.M.A., MCARDLE, S.E., AGARWAL, D., MOSELEY, P.M., GREEN, A.R., BALL, G.R., POCKLEY, A.G., ELLIS, I.O., REES, R.C. and CHAN, S.Y.T., 2016. HAGE in triple negative breast cancer (TNBC) is a novel prognostic, predictive and actionable biomarker: a transcriptomic and protein expression analysis. Clinical Cancer Research, 22 (4), pp. 905-914. ISSN 1078-0432
GREEN, A.R., SORIA, D., STEPHENS, J., POWE, D.G., NOLAN, C.C., KUNKLER, I., THOMAS, J., KERR, G.R., JACK, W., CAMERON, D., PIPER, T., BALL, G.R., GARIBALDI, J.M., RAKHA, E.A., BARTLETT, J.M.S. and ELLIS, I.O., 2016. Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series. The Journal of Pathology: Clinical Research, 2 (1), pp. 32-40. ISSN 2056-4538
ARORA, A., ABDEL-FATAH, T.M.A., AGARWAL, D., DOHERTY, R., CROTEAU, D.L., MOSELEY, P.M., HAMEED, K., GREEN, A., ALESKANDARANY, M.A., RAKHA, E.A., PATTERSON, K., BALL, G., CHAN, S.Y.T., ELLIS, I.O., BOHR, V.A., BRYANT, H.E. and MADHUSUDAN, S., 2016. Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers. Carcinogenesis, 37 (1), pp. 63-71. ISSN 0143-3334
ABDEL-FATAH, T.M., BALL, G., LEE, A.H.S., PINDER, S., MACMILAN, R.D., CORNFORD, E., MOSELEY, P.M., SILVERMAN, R., PRICE, J., LATHAM, B., PALMER, D., CHAN, A., ELLIS, I.O. and CHAN, S.Y.T., 2015. Nottingham Clinico-Pathological Response Index (NPRI) after Neoadjuvant Chemotherapy (Neo-ACT) Accurately Predicts Clinical Outcome in Locally Advanced Breast Cancer. Clinical Cancer Research, 21 (5), pp. 1052-1062. ISSN 1078-0432
ALBARAKATI, N., ABDEL-FATAH, T.M.A., DOHERTY, R., RUSSELL, R., AGARWAL, D., MOSELEY, P., PERRY, C., ARORA, A., ALSUBHI, N., SEEDHOUSE, C., RAKHA, E.A., GREEN, A., BALL, G., CHAN, S., CALDAS, C., ELLIS, I.O. and MADHUSUDAN, S., 2015. Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy. Molecular Oncology, 9 (1), pp. 204-217. ISSN 1574-7891
ARORA, A., ABDEL-FATAH, T.M.A., AGARWAL, D., DOHERTY, R., MOSELEY, P.M., ALESKANDARANY, M.A., GREEN, A.R., BALL, G., ALSHAREEDA, A.T., RAKHA, E.A., CHAN, S.Y.T., ELLIS, I.O. and MADHUSUDAN, S., 2015. Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer. Molecular Cancer Therapeutics, 14 (4), pp. 1057-1065. ISSN 1535-7163
ABDEL-FATAH, T.M.A., MIDDLETON, F.K., ARORA, A., AGARWAL, D., CHEN, T., MOSELEY, P.M., PERRY, C., DOHERTY, R., CHAN, S., GREEN, A.R., RAKHA, E., BALL, G., ELLIS, I.O., CURTIN, N.J. and MADHUSUDAN, S., 2015. Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer. Molecular Oncology, 9 (3), pp. 569-585. ISSN 1574-7891
POWE, D.G., DHONDALAY, G.K.R., LEMETRE, C., ALLEN, T., HABASHY, H.O., ELLIS, I.O., REES, R. and BALL, G., 2014. DACH1: its role as a classifier of long term good prognosis in luminal breast cancer. PLOS ONE, 9 (1). ISSN 1932-6203
ABDEL-FATAH, T., ARORA, A., AGARWAL, D., MOSELEY, P., PERRY, C., THOMPSON, N., GREEN, A.R., RAKHA, E., CHAN, S., BALL, G., ELLIS, I.O. and MADHUSUDAN, S., 2014. Adverse prognostic and predictive significance of low DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression in early-stage breast cancers. Breast Cancer Research and Treatment, 146 (2), pp. 309-320. ISSN 0167-6806
ABDEL-FATAH, T., ARORA, A., AGARWAL, D., MOSELEY, P., PERRY, C., THOMPSON, N., GREEN, A.R., RAKHA, E., CHAN, S., BALL, G., ELLIS, I.O. and MADHUSUDAN, S., 2014. Adverse prognostic and predictive significance of low DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression in early-stage breast cancers. Breast Cancer Research and Treatment, 146 (2), pp. 309-320. ISSN 0167-6806
ABDEL-FATAH, T.M.A., RUSSELL, R., AGARWAL, D., MOSELEY, P., ABAYOMI, M., PERRY, C., ALBARAKATI, N., BALL, G., CHAN, S., CALDAS, C., ELLIS, I.O. and MADHUSUDAN, S., 2014. DNA polymerase B deficiency is linked to aggressive breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression in multiple cohorts. Molecular Oncology, 8 (3), pp. 520-532. ISSN 1574-7891
ABDEL-FATAH, T.M.A., RUSSELL, R., ALBARAKATI, N., MALONEY, D.J., DORJSUREN, D., RUEDA, O.M., MOSELEY, P., MOHAN, V., SUN, H., ABBOTTS, R., MUKHERJEE, A., AGARWAL, D., ILLUZZI, J.L., JADHAV, A., SIMEONOV, A., BALL, G., CHAN, S., CALDAS, C., ELLIS, I.O., WILSON, D.M. and MADHUSUDAN, S., 2014. Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer. Molecular Oncology, 8 (7), pp. 1326-1338. ISSN 1574-7891
ABDEL-FATAH, T.M.A., MCARDLE, S.E.B., JOHNSON, C., MOSELEY, P.M., BALL, G.R., POCKLEY, A.G., ELLIS, I.O., REES, R.C. and CHAN, S.Y.T., 2014. HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer. British Journal of Cancer, 110 (10), pp. 2450-2461. ISSN 1532-1827
ABDEL-FATAH, T.M.A., PERRY, C., DICKINSON, P., BALL, G., MOSELEY, P., MADHUSUDAN, S., ELLIS, I.O. and CHAN, S.Y.T., 2013. Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings. Annals of Oncology, 24 (11), pp. 2801-2807. ISSN 1569-8041
ILYAS, M., GRABSCH, H., ELLIS, I.O., WOMACK, C., BROWN, R., BERNEY, D., FENNEL, D., SALTO-TELLEZ, M., JENKINS, M., LANDBERG, G., BYERS, R., TREANOR, D., HARRISON, D., GREEN, A.R., BALL, G. and HAMILTON, P., 2013. Guidelines and considerations for conducting experiments using tissue microarrays. Histopathology, 62 (6), pp. 827-839. ISSN 1365-2559
GREEN, A.R., POWE, D.G., RAKHA, E.A., SORIA, D., LEMETRE, C., NOLAN, C.C., BARROS, F.F.T., MACMILLAN, R.D., GARIBALDI, J.M., BALL, G.R. and ELLIS, I.O., 2013. Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers. British Journal of Cancer, 109 (7), pp. 1886-1894. ISSN 0007-0920
LAVERSIN, S.A.-S., PHATAK, V.M., POWE, D.G., LI, G., MILES, A.K., HUGHES, D.C., BALL, G.R., ELLIS, I.O., GRITZAPIS, A.D., MISSITZIS, I., MCARDLE, S.E.B. and REES, R.C., 2013. Identification of novel breast cancer-associated transcripts by uniGene database mining and gene expression analysis in normal and malignant cells. Genes, Chromosomes and Cancer, 52 (3), pp. 316-329. ISSN 1098-2264
BAKER, B.G., BALL, G.R., RAKHA, E.A., NOLAN, C.C., CALDAS, C., ELLIS, I.O. and GREEN, A.R., 2013. Lack of expression of the proteins GMPR2 and PPARα are associated with the basal phenotype and patient outcome in breast cancer. Breast Cancer Research and Treatment, 137 (1), pp. 127-137. ISSN 0167-6806
ABDEL-FATAH, T.M.A., ALBARAKATI, N., BOWELL, L., AGARWAL, D., MOSELEY, P., HAWKES, C., BALL, G., CHAN, S., ELLIS, I.O. and MADHUSUDAN, S., 2013. Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy. Breast Cancer Research and Treatment, 142 (3), pp. 515-527. ISSN 0167-6806
SULTANA, R., ABDEL-FATAH, T., ABBOTTS, R., HAWKES, C., ALBARAKATA, N., SEEDHOUSE, C., BALL, G., CHAN, S., RAKHA, E.A., ELLIS, I.O. and MADHUSUDAN, S., 2013. Targeting XRCC1 deficiency in breast cancer for personalized therapy. Cancer Research, 73 (5), pp. 1621-1634. ISSN 1538-7445
SORIA, D., GARIBALDI, J.M., GREEN, A.R., POWE, D.G., NOLAN, C.C., LEMETRE, C., BALL, G. and ELLIS, I.O., 2013. A quantifier-based fuzzy classification system for breast cancer patients. Artificial Intelligence in Medicine, 58 (3), pp. 175-184. ISSN 0933-3657
ALESKANDARANY, M.A., NEGM, O.H., RAKHA, E.A., AHMED, M.A.H., NOLAN, C.C., BALL, G.R., CALDAS, C., GREEN, A.R., TIGHE, P.J. and ELLIS, I.O., 2012. TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome. Breast Cancer Research and Treatment, 136 (2), pp. 419-427. ISSN 0167-6806
STORR, S.J., MOHAMMED, R.A.A., WOOLSTON, C.M., GREEN, A.R., PARR, T., SPITERI, I., CALDAS, C., BALL, G.R., ELLIS, I.O. and MARTIN, S.G., 2011. Calpastatin is associated with lymphovascular invasion in breast cancer. The Breast, 20 (5), pp. 413-418. ISSN 0960-9776
ABDEL-FATAH, A., POWE, D.G., BALL, G., LOPEZ-GARCIA, M.A., HABASHY, H.O., GREEN, A.R., REIS-FILHO, J.S. and ELLIS, I.O., 2010. Proposal for a modified grading system based on mitotic index and Bcl2 provides objective determination of clinical outcome for patients with breast cancer. Journal of Pathology, 222 (4), pp. 388-399. ISSN 1096-9896
HABASHY, H.O., POWE, D.G., STAKA, C.M., RAKHA, E.A., BALL, G., GREEN, A.R., ALESKANDARANY, M., PAISH, E.C., MACMILLAN, R.D., NICHOLSON, R.I., ELLIS, I.O. and GEE, J.M.W., 2010. Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. Breast Cancer Research and Treatment, 119 (2), pp. 283-293. ISSN 0167-6806
SORIA, D., GARIBALDI, J.M., AMBROGI, F., GREEN, A.R., POWE, D., RAKHA, E., MACMILLAN, R.D., BLAMEY, R.W., BALL, G., LISBOA, P.J.G., ETCHELLS, T.A., BORRACCH, P., BIGANZOLI, E. and ELLIS, I.O., 2010. A methodology to identify consensus classes from clustering algorithms applied to immunohistochemical data from breast cancer patients. Computers in Biology and Medicine, 40 (3), pp. 318-330. ISSN 1862-8346
HABASHY, H.O., POWE, D.G., RAKHA, E.A., BALL, G., MACMILLAN, R.D., GREEN, A.R. and ELLIS, I.O., 2010. The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype. Breast Cancer Research and Treatment, 120 (3), pp. 603-612. ISSN 0167-6806
ZHANG, H., RAKHA, E.A., BALL, G.R., SPITERI, I., ALESKANDARANY, M., PAISH, E.C., POWE, D.G., MACMILLAN, R.D., CALDAS, C., ELLIS, I.O. and GREEN, A.R., 2010. The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer. Breast Cancer Research and Treatment, 121 (1), pp. 41-51. ISSN 0167-6806
LANCASHIRE, L.J., POWE, D.G., REIS-FILHO, J.S., RAKHA, E., LEMETRE, C., WEIGELT, B., ABDEL-FATAH, T.M., GREEN, A.R., MUKTA, R., BLAMEY, R., PAISH, E.C., REES, R.C., ELLIS, I.O. and BALL, G.R., 2010. A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks. Breast cancer research and treatment, 120 (1), pp. 83-93. ISSN 0167-6806
ELSHEIKH, S.E., GREEN, A.R., RAKHA, E.A., POWE, D.G., AHMED, R.A., COLLINS, H.M., SORIA, D., GARIBALDI, J.M., PAISH, C.E., AMMAR, A.A., GRAINGE, M.J., BALL, G.R., ABDELGHANY, M.K., MARTINEZ-POMARES, L., HEERY, D.M. and ELLIS, I.O., 2009. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Research, 69 (9), pp. 3802-3809. ISSN 0008-5472
HABASHY, H.O., POWE, D.G., RAKHA, E.A., BALL, G., PAISH, C., GEE, J., NICHOLSON, R.I. and ELLIS, I.O., 2008. Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance. European Journal of Cancer, 44 (11), pp. 1541-1551. ISSN 0959-8049
MURALI-GANESH, R., POWE, D.G., PANCHOLI, A., BALL, G.R., RAKHA, E. and ELLIS, I.O., 2007. ALCAM is an independent predictor of survival in unselected breast cancer. Ejc Supplements, 5 (3), pp. 28-29. ISSN 1359-6349
MITCHELL, M.J., WISHART, G., BLAMEY, R.W., BALL, G.R. and ELLIS, I.O., 2007. Absolute gain. Ejc Supplements, 5 (3), p. 35. ISSN 1359-6349
GREEN, A.R., GARIBALDI, J.M., SORIA, D., AMBROGI, F., BALL, G., LISBOA, P.J.G., ETCHELLS, T.A., BORACCHI, P., BIGANZOLI, E., MACMILLAN, R.D., BLAMEY, R.W. and ELLIS, I.O., 2007. Identification of sub-classes of breast cancer through consensus derived from automated clustering methods. Ejc Supplements, 5 (3), p. 18. ISSN 1359-6349
BLAMEY, R.W., MITCHELL, M.J., BALL, G.R., GREEN, A., RAMPAUL, R., PINDER, S., LEE, A., MACMILLAN, R.D. and ELLIS, I.O., 2007. Prognostic estimation: re-analysis of data from cases diagnosed in 1990-99 by Cox proportional hazards method. Ejc Supplements, 5 (3), p. 28. ISSN 1359-6349
BLAMEY, R.W., PINDER, S.E., BALL, G.R., ELLIS, I.O., ELSTON, C.W., MITCHELL, M.J. and HAYBITTLE, J.L., 2007. Reading the prognosis of the individual with breast cancer. European Journal of Cancer, 43 (10), pp. 1545-1547. ISSN 0959-8049
BLAMEY, R.W., ELLIS, I.O., PINDER, S.E., LEE, A.H.S., MACMILLAN, R.D., MORGAN, D.A.L., ROBERTSON, J.F.R., MITCHELL, M.J., BALL, G.R., HAYBITTLE, J.L. and ELSTON, C.W., 2007. Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. European Journal of Cancer, 43 (10), pp. 1548-1555. ISSN 0959-8049
RAMPAUL, R.S., MITCHELL, M.J., PINDER, S.E., PAISH, C.E., BLAMEY, R.W., BD, E.R., BALL, G., ROBERTSON, J.F. and ELLIS, I.O., 2007. The effect of HER-2 overexpression on survival in early breast cancer. Ejc Supplements, 5 (3), pp. 27-28. ISSN 1359-6349
RAMPAUL, R.S., BALL, G., PAISH, C., PINDER, S.E., MITCHELL, M.J., BLAMEY, R.W., ROBERTSON, J.F.R., NICHOLSON, R.I., GEE, J.M., GULLICK, W.J. and ELLIS, I.O., 2007. erbB Signalling in breast cancer. Ejc Supplements, 5 (3), p. 32. ISSN 1359-6349
THOMPSON, N., LEIGH-BRAMWELL, S., POWE, D.G., BALL, G., RAKHA, E., WILLIAMS, J., PAISH, E.C. and ELLIS, I.O., 2006. Breast cancer profiling: A minimised panel of predictive markers for survival. Journal of Pathology, 210, p. 59. ISSN 0022-3417
BD, E.R., BALL, G., PINDER, S.E., RAKHA, E., PAISH, C., ROBERTSON, J.F.R., MACMILLAN, D., BLAMEY, R.W. and ELLIS, I.O., 2005. High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. International Journal of Cancer, 116 (3), pp. 340-350. ISSN 0020-7136
EL-REHIM, D.M.A., BALL, G., PINDER, S. and ELLIS, I.O., 2004. Molecular classification of breast carcinoma based on the protein expression immunoprofiles. Journal of Pathology, 204. ISSN 0022-3417
BALL, G., MIAN, S., HOLDING, F., ALLIBONE, R.O., LOWE, J., ALI, S., LI, G., MCCARDLE, S., ELLIS, I.O., CREASER, C. and REES, R.C., 2002. An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers. Bioinformatics, 18 (3), pp. 395-404. ISSN 1367-4803
